New research reveals the complexities of making ‘Just in Case’ medications available for people nearing the end of life at home. Patients, informal carers and healthcare professionals interviewed for the research said their presence could cause distress as well as comfort. Some families reported difficulties persuading nurses to administer the medications to relieve suffering.
The ‘Just in Case’ medication packs contain injectable medicines like morphine. They are prescribed in case symptoms such as pain, nausea and breathlessness develop when a person has become too weak to take oral medications. They are in place for around half of adults dying at home or in care homes in England.
The research was conducted by Dr Ben Bowers at the Primary Care Unit, University of Cambridge, also a community palliative care nurse.
Dr Bowers said: “The last days of life at home are hard to investigate and so how these medications are perceived by patients themselves and by their caregivers has remained a mystery to those without recent personal experience of care.”
The thorough research investigated the end of life care of eleven patients through a series of interviews. The patients, aged between 65 and 94, were all prescribed ‘Just in Case’ injectable medications. Six of the patients themselves took part in at least one interview, along with nine informal caregivers, three GPs and three nurses. In total, 28 interviews were carried out, some during the last days of life and bereavement.
A source of unease as well as comfort
The results show that most patients and informal caregivers appreciated having injectable medications available in the home.
But, for some, the medication pack was at the same time viewed as an unwelcome reminder of impending death at a time when they were trying to cope with ever-changing circumstances and maintain a sense of optimism.
Detailed explanations needed
Most of the patients and informal caregivers felt in the dark about the purpose of the medications. They did not remember having a detailed conversation about what they were for or how they could be used.
The vague term ‘Just in Case’ medications didn’t help, and most of the patients and caregivers didn’t understand the purpose of injectable medications or the practicalities of managing symptoms in the last days of life.
Eleven participants said they had to search for information about medications and five participants took the opportunity to ask the researcher carrying out the interview what individual medications were for.
“I actually Googled what they were, but it would have been nice for somebody, I think, to have just spent a short time explaining what they were,” said Amelia, informal caregiver
Variable experiences of getting medications administered
Patients who could clearly express their preferences did not experience difficulties with nurses starting injections: their requests for medications were met swiftly. But five informal caregivers said they had to convince nurses to start injectable medications after patients appeared to be in pain or distress.
Alice, an informal caregiver, was with her mother when she became particularly distressed. She recalled having to advocate strongly for injectable medications to be given when a nurse, who did not know her mother, visited the care home and assessed that they were not needed.
Another informal caregiver, Sarah, said that, despite repeated attempts, she was never able to convince the nurses to give injectable medication for her friend’s significant pain and distress in the days before his death. She said:
“It upset me … They [the district nursing team] should be communicating with us, asking us, and work as a team, but it just didn’t feel like that … They [anticipatory medications] were useless because nobody would give him anything.”
However, getting drugs administered during the night was largely uncomplicated, with nurses usually visiting within an hour of being telephoned.
“Ruth was quite distressed about the pain… I phoned the district nurse, and they were there within half an hour … They told me that they were giving her a part dose of a morphine, and if it wasn’t enough in an hour’s time or so just to ring back and they could give her the other half,” said Mark, an informal caregiver.
The findings challenge the widespread perception that once ‘Just in Case’ injectable medications are in patients’ homes, patients will receive timely and appropriate care. The research team emphasise that the prescribing of injectable medications is a nuanced and complex intervention and requires tailored and honest discussion about possible last days of life symptoms and the medications. In particular, they suggest that nurses deciding whether to administer medications should carefully listen to informal caregivers’ insights into patient discomfort and distress, especially when individuals are no longer able to communicate their needs.
The National Institute for Health Research (NIHR) School for Primary Care Research and the RCN Foundation funded this research.
————————————-
Reference
Bowers B, Pollock K, Barclay S. Simultaneously reassuring and unsettling: a longitudinal qualitative study of community anticipatory medication prescribing for older patients. Age and Ageing. 8 December 2022. doi/10.1093/ageing/afac293
About the University of Cambridge’s Primary Care Unit
This research was conducted at the Primary Care Unit, which sits within the Department for Public Health and Primary Care at the University of Cambridge. We aim to reduce the burden of ill health through our research and teaching. We work to identify and target behaviours that lead to chronic disease, improve the early detection of disease and improve the quality of health services.
The mission of the University of Cambridge is to contribute to society through the pursuit of education, learning and research at the highest international levels of excellence. To date, 109 affiliates of the University have won the Nobel Prize.
Founded in 1209, the University comprises 31 autonomous Colleges and 150 departments, faculties and institutions. Cambridge is a global university. Its 19,000 student body includes 3,700 international students from 120 countries. Cambridge researchers collaborate with colleagues worldwide, and the University has established larger-scale partnerships in Asia, Africa and America.
The University sits at the heart of the ‘Cambridge cluster’, which employs more than 61,000 people and has in excess of £15 billion in turnover generated annually by the 5,000 knowledge-intensive firms in and around the city. The city publishes 316 patents per 100,000 residents.
Leave a Reply